Cita APA (7a ed.)

M, S., S, U., B, S., CG, M., IK, P., & R, J. (2017). In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts. Dove Medical Press.

Cita Chicago Style (17a ed.)

M, Sreeranganathan, Uthaman S, Sarmento B, Mohan CG, Park IK, y Jayakumar R. In Vivo Evaluation of Cetuximab-conjugated Poly(γ-glutamic Acid)-docetaxel Nanomedicines in EGFR-overexpressing Gastric Cancer Xenografts. Dove Medical Press, 2017.

Cita MLA (8a ed.)

M, Sreeranganathan, et al. In Vivo Evaluation of Cetuximab-conjugated Poly(γ-glutamic Acid)-docetaxel Nanomedicines in EGFR-overexpressing Gastric Cancer Xenografts. Dove Medical Press, 2017.